Summary

● The company has solid fundamentals for a short-term investment strategy.


Strengths

● The stock, which is currently worth 2021 to 0.76 times its sales, is clearly overvalued in comparison with peers.

● 

● For the past twelve months, EPS forecast has been revised upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.


Weaknesses

● According to forecast, a sluggish sales growth is expected for the next fiscal years.

● 

● The company sustains low margins.

● The firm trades with high earnings multiples: 32.15 times its 2021 earnings per share.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.